Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies
Thyroid2014Vol. 24(7), pp. 1139–1145
Citations Over TimeTop 10% of 2014 papers
Cosimo Durante, Sara Tognini, Teresa Montesano, Fabio Orlandi, Massimo Torlontano, Efisio Puxeddu, Marco Attard, Giuseppe Costante, Dario Tumino, Domenico Meringolo, Rocco Bruno, Fabiana Trulli, Maria Toteda, Adriano Redler, Giuseppe Ronga, Sébastiano Filetti, Fabio Monzani, on behalf of the PTC Study Group
Abstract
PTC patients with positive serum TgAb titer during the first year after primary treatment were more likely to have persistent/recurrent disease than those who were consistently TgAb-negative. Negative titers at 1 year may be associated with more favorable outcomes.
Related Papers
- → Autoantibodies to Thyroglobulin in Health and Disease(2000)28 cited
- → Immunoanalytical profile of thyroglobulin antibodies(2018)5 cited
- → Anti-thyroglobulin autoantibodies in sera from patients with chronic thyroiditis and from healthy subjects: differences in cross-reactivity with thyroid peroxidase(1990)31 cited
- → Thyroid-Specific Autoantibodies Studied by Passive Cutaneous Anaphylaxis of Guinea Pig.(1958)22 cited
- → Absence of Thyroid Auto-antibody in Experimental Radiation Thyroiditis(1961)5 cited